seed
Stage
About
Amara Therapeutics develops digital therapeutics for women with urinary incontinence, offering a CE-marked smartphone-delivered behavioural therapy (RiSolve) for overactive bladder. The company provides app-based non-drug treatment combined with virtual clinician support and has run multisite clinical evaluations.
Explore Amara Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.